Clinical Trials in Philadelphia

Showing 961-980 of 9,968 trials

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

NCT07008469

A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous Delpacibart Etedesiran (abbreviated del-desiran, formerly AOC 1001) for the Treatment of Myotonic Dystrophy Type 1

Myotonic Dystrophy Type 1DM1Myotonic Dystrophy+5 more

Avidity Biosciences, Inc.230 participantsStarted Jul 2025

Los Angeles, California, United States • Stanford, California, United States • Denver, Colorado, United States +17 more locations

RECRUITINGPhase 4< 1 mile

A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

NCT05215353

The researchers are doing this study to compare how music therapy and cognitive behavioral therapy, given virtually, may be able to reduce anxiety in people who have had cancer. In addition, this study will see if certain factors affect how well participants respond to music therapy or cognitive behavioral therapy. For example, the researchers will see if personal characteristics (like age, sex, race, and education) and ways of thinking (like expectations of therapy) may affect how well participants respond.

Survivorship

Memorial Sloan Kettering Cancer Center368 participantsStarted Jan 2022

Miami, Florida, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

Find Trials by Condition in Philadelphia

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 50 Years of Age With Non-congenital Myotonic Dystrophy Type 1

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma

A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass